Hanifa, Y., Fielding, K.L., Chihota, V.N., Adonis, L., Charalambous, S., Foster, N., Karstaedt, A., McCarthy, K., Nicol, M.P., Ndlovu, N.T. and Sinanovic, E., 2018. The utility of repeat Xpert MTB/RIF testing to diagnose tuberculosis in HIV-positive adults with initial negative result. Gates Open Research, 2, pp.22-22.
Chihota, V.N., Ntshiqa, T., Maenetje, P., Mansukhani, R., Velen, K., Hawn, T.R., Wallis, R., Grant, A.D., Churchyard, G.J. and Fielding, K., 2022. Resistance to Mycobacterium tuberculosis infection among highly TB exposed South African gold miners. PloS one, 17(3), p.e0265036.
Wallis, R.S., Ginindza, S., Beattie, T., Arjun, N., Likoti, M., Sebe, M., Edward, V.A., Rassool, M., Ahmed, K., Fielding, K. and Ahidjo, B.A., 2022. Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial. Plos one, 17(2), p.e0252097.
Mulenga, H., Fiore-Gartland, A., Mendelsohn, S.C., Penn-Nicholson, A., Mbandi, S.K., Borate, B., Musvosvi, M., Tameris, M., Walzl, G., Naidoo, K. and Churchyard, G., 2022. The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk. EBioMedicine, 77, p.103886.
Takuva, S., Karuna, S.T., Juraska, M., Rudnicki, E., Edupuganti, S., Anderson, M., De La Grecca, R., Gaudinski, M.R., Sehurutshi, A., Orrell, C. and Naidoo, L., 2022. Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials. JAIDS Journal of Acquired Immune Deficiency Syndromes, 89(4), pp.405-413.
Mshweshwe-Pakela, N., Mabuto, T., Ntombela, N., Hlongwane, M., Kubeka, G., Kerrigan, D.L. and Hoffmann, C.J., 2022. Facilitators and barriers to implementing provider-initiated HIV counselling and testing at the clinic-level in Ekurhuleni District, South Africa. Implementation science communications, 3(1), pp.1-9.
Sam-Agudu, N.A., Quakyi, N.K., Masekela, R., Zumla, A. and Nachega, J.B., 2022. Children and adolescents in African countries should also be vaccinated for COVID-19. BMJ Global Health, 7(2), p.e008315.
Wallis, R.S., Ginindza, S., Beattie, T., Arjun, N., Likoti, M., Sebe, M., Edward, V.A., Rassool, M., Ahmed, K., Fielding, K. and Ahidjo, B.A., 2022. Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial. Plos one, 17(2), p.e0252097.
